title: G(2) chromosomal radiosensitivity in Danish survivors of childhood and adolescent cancer and their offspring.
abstract: In order to investigate the relationship between chromosomal radiosensitivity and early-onset cancer, the G(2) chromosomal radiosensitivity assay was undertaken on a group of 23 Danish survivors of childhood and adolescent cancer, a control group comprising their partners and a group of 38 of their offspring. In addition, the previously reported in-house control group from Westlakes Research Institute (WRI) was extended to 27 individuals. When using the 90th percentile cutoff for the WRI control group, the proportion of individuals with elevated radiosensitivity was 11, 35, 52 and 53% for the WRI control, partner control, cancer survivor and the offspring groups, respectively, with significant differences between the WRI control group and the cancer survivor group (P=0.002) and the offspring group (P<0.001). However, while the comparisons with the WRI control group support an association of chromosomal radiosensitivity with cancer predisposition, when the partner control group was used to define the radiosensitivity cutoff point, no significant differences in radiosensitivity profiles were found between the partner control group and either the cancer survivor group or the offspring group. The failure to distinguish between the G(2) aberration profiles of the apparently normal group of partners and the cancer survivor group suggests that any association with cancer should be viewed with caution, but also raises questions as to the suitability of the partners of cancer survivors to act as an appropriate control group. Heritability of the radiosensitive phenotype was examined by segregation analysis of the Danish families and suggested that 67.3% of the phenotypic variance of G(2) chromosomal radiosensitivity is attributable to a putative major gene locus with dominant effect.
authors.affiliation: Westlakes Research Institute, Moor Row, Cumbria CA24 3JY, UK. Gillian.Curwen@westlakes.ac.uk
authors.forename: G B
authors.initials: GB
authors.lastname: Curwen
authors.forename: J F
authors.initials: JF
authors.lastname: Winther
authors.forename: E J
authors.initials: EJ
authors.lastname: Tawn
authors.forename: V
authors.initials: V
authors.lastname: Smart
authors.forename: C A
authors.initials: CA
authors.lastname: Whitehouse
authors.forename: G S
authors.initials: GS
authors.lastname: Rees
authors.forename: J H
authors.initials: JH
authors.lastname: Olsen
authors.forename: P
authors.initials: P
authors.lastname: Guldberg
authors.forename: C
authors.initials: C
authors.lastname: Rechnitzer
authors.forename: H
authors.initials: H
authors.lastname: Schrøder
authors.forename: P E
authors.initials: PE
authors.lastname: Bryant
authors.forename: X
authors.initials: X
authors.lastname: Sheng
authors.forename: H S
authors.initials: HS
authors.lastname: Lee
authors.forename: R
authors.initials: R
authors.lastname: Chakraborty
authors.forename: J D
authors.initials: JD
authors.lastname: Boice
mesh_terms: D000293:Adolescent; D000328:Adult; D017668:Age of Onset; D002648:Child; D002675:Child, Preschool; D002869:Chromosome Aberrations / Q000528:radiation effects; D002877:Chromosomes, Human / Q000235:genetics* / Q000528:radiation effects*; D015331:Cohort Studies; D004249:DNA Damage; D005260:Female; D016195:G2 Phase / Q000528:radiation effects*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D009369:Neoplasms / Q000235:genetics*; D010865:Pilot Projects; D011836:Radiation Tolerance / Q000235:genetics*; D017741:Survivors